Literature DB >> 9607302

Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.

I V Kurochkin1.   

Abstract

Insulin-degrading enzyme (IDE) is an evolutionarily conserved neutral thiol metalloprotease expressed in all mammalian tissues whose biological role is not well established. IDE has highly selective substrate specificity. It degrades insulin, glucagon, atrial natriuretic peptide, transforming growth factor alpha but does not act on related hormones and growth factors. The structural properties determining whether a peptide is an IDE substrate are essentially unknown. The reported cleavage sites are not consistent with simple peptide-bond recognition and it was proposed that IDE recognizes in its substrates some elements of tertiary structure. We noticed that although IDE substrates are functionally unrelated, the majority of them share a specific property, an ability to form under certain conditions amyloid fibrils. Utilizing the residue pattern recognition procedure, this study reveals a common motif in the sequences of IDE substrates, HNHHHPSH, where H is wholly or partly hydrophobic character, N is small and neutral, P is polar, and S is polar and/or small amino acid residue. It is proposed that this sequence motif predetermines a structure recognized by IDE. The identified motif appears to be essentially the same as the proposed earlier consensus sequence for amyloid-forming peptides [Turnell and Finch, J. Mol. Biol. 227 (1992) 1205-1223]. The study suggests that IDE may play a role in elimination of potentially toxic amyloidogenic peptides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607302     DOI: 10.1016/s0014-5793(98)00422-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

1.  Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB.

Authors:  M Gross; D K Wilkins; M C Pitkeathly; E W Chung; C Higham; A Clark; C M Dobson
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

2.  A common genetic system for functional studies of pitrilysin and related M16A proteases.

Authors:  Benjamin J Alper; Tatyana E Nienow; Walter K Schmidt
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

3.  Yeast Ste23p shares functional similarities with mammalian insulin-degrading enzymes.

Authors:  Benjamin J Alper; Jarrad W Rowse; Walter K Schmidt
Journal:  Yeast       Date:  2009-11       Impact factor: 3.239

4.  Highly amyloidogenic two-chain peptide fragments are released upon partial digestion of insulin with pepsin.

Authors:  Marcin Piejko; Robert Dec; Viktoria Babenko; Agnieszka Hoang; Monika Szewczyk; Paweł Mak; Wojciech Dzwolak
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

5.  Cell-permeable, small-molecule activators of the insulin-degrading enzyme.

Authors:  Sayali S Kukday; Surya P Manandhar; Marissa C Ludley; Mary E Burriss; Benjamin J Alper; Walter K Schmidt
Journal:  J Biomol Screen       Date:  2012-06-26

6.  Ste24p Mediates Proteolysis of Both Isoprenylated and Non-prenylated Oligopeptides.

Authors:  Emily R Hildebrandt; Buenafe T Arachea; Michael C Wiener; Walter K Schmidt
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

7.  Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase.

Authors:  A S Balasubramanian
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

8.  Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

Authors:  A Pérez; L Morelli; J C Cresto; E M Castaño
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

9.  Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

Authors:  Christina Yfanti; Karin Mengele; Apostolos Gkazepis; Gregor Weirich; Cecylia Giersig; Wen-Liang Kuo; Wei-Jen Tang; Marsha Rosner; Manfred Schmitt
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

Review 10.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.